TXP Medical Co., Ltd.
PrivateLast Round
Series C
Oct 23, 2024
Est. Valuation
$77.18M
Total Funding Raised
$33.33M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
TXP Medical Co., Ltd. operates in Healthcare & Life Sciences and is based in Tokyo. Its latest recorded funding round was a Series C round in October 2024.
TXP Medical Co., Ltd. is a health-tech company that develops and provides medical data systems and platforms for emergency and intensive care, including the NEXT Stage ER series, to improve medical care quality through data-driven decision-making.
Sector
Healthcare & Life Sciences
Verticals
EHR & EMR, Vertical SaaS, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TXP Medical Co., Ltd. Comparables
Compare TXP Medical Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Smart119 Inc. | 84% | |
| ESO Solutions | 74% | |
| ImageTrend | 73% |
For institutional investors. Book with your work email.
TXP Medical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Oct 23, 2024 | ||||
| Series B | Apr 5, 2022 | ||||
| Series A | Nov 30, 2020 | ||||
| Series A | Jul 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
TXP Medical Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UTEC (The University of Tokyo Edge Capital Partners) | Series B, Series A |
| MPower Partners | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2026
Reached 100 large hospital customers with 50% market share.
- May 26, 2026
Hiroshima Prefecture is now using its NSER mobile system.
For institutional investors. Book with your work email.
TXP Medical Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TXP Medical Co., Ltd.'s valuation, stock price, and market status.
Is TXP Medical Co., Ltd. a public or private company?
TXP Medical Co., Ltd. is a private company.
What is the current stock price of TXP Medical Co., Ltd.?
TXP Medical Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks TXP Medical Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TXP Medical Co., Ltd. worth (valuation)?
TXP Medical Co., Ltd.'s valuation is estimated at $77.2M based on funding round data.
Can I buy TXP Medical Co., Ltd. stock?
TXP Medical Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TXP Medical Co., Ltd.'s last funding round?
TXP Medical Co., Ltd.'s most recent funding round was Series C on October 23, 2024.
Who are the main investors in TXP Medical Co., Ltd.?
Key investors in TXP Medical Co., Ltd. include UTEC (The University of Tokyo Edge Capital Partners).
Will TXP Medical Co., Ltd. IPO soon?
No public IPO plans have been announced for TXP Medical Co., Ltd..
How can I track TXP Medical Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in TXP Medical Co., Ltd.'s shares on secondary markets.